| Antioxidant agents for delaying diabetic kidney disease progression: a systematic review and meta-analysis D Bolignano, V Cernaro, G Gembillo, R Baggetta, M Buemi, G D’Arrigo PloS one 12 (6), e0178699, 2017 | 120 | 2017 |
| Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: an updated systematic review and meta-analysis A Pisano, V Cernaro, G Gembillo, G D’Arrigo, M Buemi, D Bolignano International journal of molecular sciences 18 (11), 2283, 2017 | 64 | 2017 |
| Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors A Giandalia, AE Giuffrida, G Gembillo, D Cucinotta, G Squadrito, ... International journal of molecular sciences 22 (11), 5808, 2021 | 62 | 2021 |
| Kidney disease in diabetic patients: from pathophysiology to pharmacological aspects with a focus on therapeutic inertia G Gembillo, Y Ingrasciotta, S Crisafulli, N Luxi, R Siligato, D Santoro, ... International journal of molecular sciences 22 (9), 4824, 2021 | 57 | 2021 |
| Role of vitamin D status in diabetic patients with renal disease G Gembillo, V Cernaro, A Salvo, R Siligato, A Laudani, M Buemi, ... Medicina 55 (6), 273, 2019 | 57 | 2019 |
| Association of higher advanced oxidation protein products (AOPPs) levels in patients with diabetic and hypertensive nephropathy G Conti, D Caccamo, R Siligato, G Gembillo, E Satta, D Pazzano, ... Medicina 55 (10), 675, 2019 | 46 | 2019 |
| Kidney biopsy in type 2 diabetic patients: critical reflections on present indications and diagnostic alternatives D Santoro, M Torreggiani, V Pellicanò, V Cernaro, RM Messina, ... International journal of molecular sciences 22 (11), 5425, 2021 | 39 | 2021 |
| Cardiorenal syndrome: new pathways and novel biomarkers G Gembillo, L Visconti, MA Giusti, R Siligato, A Gallo, D Santoro, ... Biomolecules 11 (11), 1581, 2021 | 33 | 2021 |
| Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy K Kiryluk, E Sanchez-Rodriguez, XJ Zhou, F Zanoni, L Liu, N Mladkova, ... Nature genetics 55 (7), 1091-1105, 2023 | 32 | 2023 |
| Vitamin D and glomerulonephritis G Gembillo, R Siligato, M Amatruda, G Conti, D Santoro Medicina 57 (2), 186, 2021 | 32 | 2021 |
| The aggressive diabetic kidney disease in youth-onset type 2 diabetes: pathogenetic mechanisms and potential therapies M Amatruda, G Gembillo, AE Giuffrida, D Santoro, G Conti Medicina 57 (9), 868, 2021 | 31 | 2021 |
| Amyloidosis and glomerular diseases in familial Mediterranean fever R Siligato, G Gembillo, V Calabrese, G Conti, D Santoro Medicina 57 (10), 1049, 2021 | 30 | 2021 |
| Protective role of vitamin D in renal tubulopathies G Gembillo, V Cernaro, R Siligato, F Curreri, A Catalano, D Santoro Metabolites 10 (3), 115, 2020 | 28 | 2020 |
| Monocyte to HDL ratio: A novel marker of resistant hypertension in CKD patients G Gembillo, R Siligato, V Cernaro, E Satta, G Conti, A Salvo, A Romeo, ... International Urology and Nephrology 54 (2), 395-403, 2022 | 23 | 2022 |
| Potential role of copper in diabetes and diabetic kidney disease G Gembillo, V Labbozzetta, AE Giuffrida, L Peritore, V Calabrese, ... Metabolites 13 (1), 17, 2022 | 18 | 2022 |
| Maternal and fetal outcomes of pregnancy in nephrotic syndrome due to primary glomerulonephritis R Siligato, G Gembillo, V Cernaro, F Torre, A Salvo, R Granese, ... Frontiers in Medicine 7, 563094, 2020 | 18 | 2020 |
| Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis R Siligato, V Cernaro, C Nardi, F De Gregorio, G Gembillo, G Costantino, ... Expert opinion on investigational drugs 27 (11), 839-879, 2018 | 18 | 2018 |
| RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus V Cernaro, S Loddo, V Macaione, VT Ferlazzo, RM Cigala, F Crea, ... International Urology and Nephrology 52, 1125-1133, 2020 | 17 | 2020 |
| Complement inhibition therapy and dialytic strategies in paroxysmal nocturnal hemoglobinuria: The nephrologist’s opinion G Gembillo, R Siligato, V Cernaro, D Santoro Journal of Clinical Medicine 9 (5), 1261, 2020 | 16 | 2020 |
| The risks associated with percutaneous native kidney biopsies: a prospective study S Andrulli, M Rossini, G Gigliotti, G La Manna, S Feriozzi, F Aucella, ... Nephrology Dialysis Transplantation 38 (3), 655-663, 2023 | 15 | 2023 |
Santoro DomenicoUOC Nephrology and Dialysis, University of Messina在 unime.it 的电子邮件经过验证
